Long COVID

In this Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, shouts out key stories in the September issue, including an in-depth feature about what young rheumatologists expect from the field.

Adults with type 2 diabetes using metformin before or during a SARS-CoV-2 infection may have a lower risk for long COVID than those using other diabetes medications, according to findings published in Diabetes Care.

In this Healio video exclusive, Leonard Calabrese, DO, chief medical editor of Healio Rheumatology, shouts out key stories in the August issue, including an in-depth cover on language barriers as a major driver of health care disparities.

Among patients with systemic autoimmune disease in a large, real-world cohort, 29.8% reported long COVID, with frequent impacts to quality of life, following infection, according to data published in The Journal of Rheumatology.

Nearly 10% of women infected with SARS-CoV-2 during pregnancy had post-acute sequelae 6 or more months later, according to results of the RECOVER-Pregnancy study published in Obstetrics & Gynecology.

With roughly 7% of adults in the United States reporting that they have had long COVID, primary care providers can play an important role in its prevention and management, according to experts.

The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.

Patients with long COVID symptoms demonstrate elevated levels of several inflammatory molecules — findings that could have important implications in both rheumatology and the search for a potential treatment for long COVID.